ICOA yields 2000000.00% · PFE yields 6.20%● Live data
📍 ICOA pulled ahead of the other in Year 1
Combined, ICOA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ICOA + PFE for your $10,000?
ICOA, Inc. provides neutral-host wireless and wired broadband Internet services in the United States. It offers back office solutions for hotspot operators and wireless service providers. The company also provides network advisory services, as well as procures, configures, and installs network equipment; and equipment, administration, billing, business intelligence, and content management flexibility services. In addition, it engages in the design, installation, operation, maintenance, and management of neutral, common-use 802.11x standard WLAN Wi-Fi hot spot, and hot zone infrastructure facilities in airport, quick-service restaurants, universities, travel plazas, marinas, hospitality, and municipal/hot zone locations. ICOA, Inc. owns and operates approximately 1,500 broadband access installations in 45 states; the LinkSpot network in RV parks and campgrounds; and the iDockUSA network in marinas. The company was formerly known as Quintonix, Inc. and it changed its name to ICOA, Inc. in March 1989. ICOA, Inc. was founded in 1983 and is headquartered in Warwick, Rhode Island.
Full ICOA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.